The CCL2 synthesis inhibitor bindarit targets cells of the neurovascular unit, and suppresses experimental autoimmune encephalomyelitis. Ge S, Shrestha B, Paul D, Keating C, Cone R, Guglielmotti A, Pachter JS J Neuroinflammation. 2012; 9:171. PMID: 22788993. Abstract CommentRecommendBookmarkWatch
